Cas:15051-81-7 10-epi-g-Eudesmol manufacturer & supplier

Chemical Name:10-epi-g-Eudesmol

CAS.NO:15051-81-7

Synonyms:(-)-10-epi-g-Eudesmol;2-[(2R,4aS)-4a,8-Dimethyl-1,2,3,4,4a,5,6,7-octahydro-2-naphthalenyl]-2-propanol;eudesm-4-en-11-ol;10-epi-γ-Eudesmol;epi-Eudesmol;10-epi-eudesm-4-en-11-ol;10a-Eudesm-4-en-11-ol;2-Naphthalenemethanol, 1,2,3,4,4a,5,6,7-octahydro-α,α,4a,8-tetramethyl-, (2R,4aS)-;10alpha-Eudesm-4-en-11-ol;10-epi-g-Eudesmol;(-)-10-Epi-γ-eudesmol;W2237;2-[(2R,4aS)-4a,8-dimethyl-1,2,3,4,4a,5,6,7-octahydronaphthalen-2-yl]propan-2-ol

Molecular Formula:C₁₅H₂₆O

Molecular Weight:222.366

HS Code:2906199090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:301.5±11.0 °C at 760 mmHg

Density:1.0±0.1 g/cm3

Index of Refraction:1.505

PSA:20.23000

Exact Mass:222.198364

LogP:4.86

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like (-)-10-epi-g-Eudesmol chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-[(2R,4aS)-4a,8-dimethyl-1,2,3,4,4a,5,6,7-octahydronaphthalen-2-yl]propan-2-ol physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(-)-10-Epi-γ-eudesmol Use and application,10alpha-Eudesm-4-en-11-ol technical grade,usp/ep/jp grade.

Related News: As for the consumer health unit, GSK plans to demerge it by mid-2022, during which GSK will shed at least 80% of its 68% holding in the JV to shareholders. methyl S-(4-methoxybenzyl)-L-cysteinylglycinate hydrochloride manufacturers Considering that small batches present a challenge in proving the robustness of the processing equipment, the Alcami project team, in collaboration with client team members, prepared a failure mode, effects, and criticality analysis (FMECA) of the formulation and process. Pyrrolo[3,2-b]pyrrole-2,5(1H,4H)-dione,3,6-bis[4-(dimethylamino)phenyl]-1,4-bis(4-methylphenyl)- suppliers In the Phase III VICTORIA study, Verquvo met the primary efficacy objective based on a time-to-event analysis. 4-isothiocyanato-2-methyl-1-nitrobenzene vendor & factory In the Phase III VICTORIA study, Verquvo met the primary efficacy objective based on a time-to-event analysis.,In the Phase III VICTORIA study, Verquvo met the primary efficacy objective based on a time-to-event analysis.